Acute dermo-hypodermal bacterial infections in adults;Dermo-hypodermites bacteriennes aigues de l'adulte

Annales de Dermatologie et de Venereologie

Volumn 124, Issue 1, 1997, Pages 57-60

  Bedane, C ^a  

^a DUPUYTREN UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AZITHROMYCIN; CEFADROXIL; CEFALEXIN; CEFONICID; CEFOTAXIME; CIPROFLOXACIN; CLOXACILLIN; DOXYCYCLINE; ERYTHROMYCIN; NAFCILLIN; PENICILLIN G; PENICILLIN V; PIPERACILLIN PLUS TAZOBACTAM; ROXITHROMYCIN; TEMAFLOXACIN; TIMENTIN; ANTIINFECTIVE AGENT;

ANTIBIOTIC THERAPY; BACTERIAL INFECTION; CLINICAL TRIAL; DRUG EFFICACY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; REVIEW; SKIN INFECTION; ACUTE DISEASE; ARTICLE; BACTERIAL SKIN DISEASE; DRUG SCREENING; META ANALYSIS; TREATMENT OUTCOME;

ACUTE DISEASE; ANTI-BACTERIAL AGENTS; DRUG EVALUATION; HUMANS; SKIN DISEASES, BACTERIAL; TREATMENT OUTCOME;

EID: 0031053596     PISSN: 01519638     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (22)

1. Jorup Ronström C, Britton S, Gavlevik A, Gunnarsson K, Redman AC. The course, costs and complication of oral versus intravenous penicillin therapy of erysipelas. Infection 1984;12:390-4.
2. Bernard P, Plantin P, Roger H, Sassolas B, Villaret E, Legrain V, Roujeau JC, Rezvani Y, Scheimberg A. Roxithromycin versus penicillin in the treatment of erysipelas in adults: a comparative study. Br J Dermatol 1992;127:155-9.
3. Tan JS, Wischnow RM, Talan DA, Duncanson FP, Norden CW. Treatment of hospitalized patients with complicated skin and skin structure infections double blind, randomized, multicenter study of piperacillin-tazobactam versus ticarcillin-clavulanate. Antimicrob-Agents-Chemother, 1993;37:1580-6.
4. Daly JS, Worthington MJ, Andrews RJ, Brown RB, Schwanz R, Sexton DJ. Randomized, double blind trial of Cefonicid and Nafcillin in the treatment of skin and skin structure infections. Antimicrob Agents Chemother 1990;34:654-6.
5. Daniel R. Azithromycin, erythromycin and cloxacillin in the treatment of infections of skin and associated soft tissues J Int Med Res 1991;19:433-45.
6. Kiani R. Double blind, double dummy comparison of azithromycin and cephalexin in the treatment of skin and skin structure infections, Eur J Clin Microbiol Infect Dis 1991;10:880-4.
7. Heskel NS, Siepman N, Pichotta PJ, Green EM, Stoll RW. Erythromycin versus cefadroxil in the treatment of skin infections. Int J Dermatol 1992;.31:131-3.
8. Nelder KH. Double blind randomized study of oral temafloxacin and cefadroxil in patients with mild to moderately severe bacterial skin infections. Am J Med 1991;91:111S-114S.
9. Gentry LO, Ramirez-Ronda CH, Rodrigucz-Noriga E, Thadepalli H, Leal del Rosal P, Ramirez C. Oral ciprofloxacin vs. parenteral cefotaxime in the treatment of difficult skin and skin structure infections. Arch Intern Med 1989;749:2579-83.
10. Parish LC, Jungkind D. Systemic antimicrobial therapy in skin and skin structure infections: Comparison of temafloxacin and ciprofloxacin Am J Med 1991;91:115S-199S.
11. Agache P, Amblard P, Moulin G, Barrière H, Texier L, Beylot C, Bergoend H. Roxythromycin in skin and soft tissue infections. J Antimicrob Chemother 1987;20:153-6.
12. Bernard P, Risse L, Bonnetblanc JM. Traitement des dermohypodermites aiguës bactériennes de l'adulte par la pristinamycine. Ann Dermatol Venereol 1996;123:16-20.
13. Bochud-Gabellon I, Regamey C. Teicoplanin, a new antibiotic effective against Gram positive bacterial infections of the skin and soft tissues Dermatologica 1988;176:29-38.
14. Tack KJ, Wilks NE, Semerdjian G, Frazier CH, Shirin K, Puopolo A, Crosland SG, Goffe BS, Millikan L. Cefpodoxime proxetil in the treatment of skin and soft tissue infections. Drugs 1991;42:51-6.
15. Ginsberg MB. Cellulitis, analysis of 101 cases and review of the literature Southern Medical Journal 1981;74:530-3.
16. Lorette G, Py F, Machet L, Vaillant L. Erysipèle, étude rétrospective de 100 cas. Med et Hyg 1990;48:764-8.
17. Crickx B, Chevron F, Sigal-Nahum, Bilet S, Faucher F, Picard C, Lazareth I, Belaich S. Erysipèle : données épidémiologiques, cliniques et thérapeutiques Ann Dermatol Venereol 1991;118:11-6.
18. Lanoux P, Penalba C, Legin C, Kivade M, Reveil JC. L'érysipèle, à propos de 118 observations. Med Mal Infect 1993;23:908-12.
19. Cherkassov VL, Bolshakova TD, Kusnetsov VA, Obrasberdyev S, Mikerin SM. The treatment of patients with the hemorrhagic form of erysipelas by using amben and parmidine. Vrach-Delo 1990;4:113-5.
20. Jorup-Ronström C, Britton S. Recurrent erysipelas, predisposing factors and costs prophylaxis. Infections 1987;15:105-6.
21. Sjöblom AO, Eriksson B, Jorup-Ronström C, Karkkonen K, Lindqvist M. Antibiotic prophylaxis in recurrent erysipelas. Infections 1993;6:390-4.
22. Haustein UF, Biella U, Tausch I, Knoll H. Die Behandlung des chronisch- rezidivieren Erysipels mit Streptokokkenvakzine. Hautarzt 1989;40:215-21.